Stock · NSE
CIPLA
1,439.40▼ 1.90 (-0.13%)Last 2 days · 15m candles10/7/2026, 23:33:45
Open: 1,443.10High: 1,451.90Low: 1,436.50Prev: 1,441.30
VERIFIEDET Markets·21h★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla's Weekly Trading MetricsAI summary· NEUTRAL
- ·Cipla's share price experienced weekly trading activity.
- ·The provided information focuses on Cipla's weekly trading metrics.
- ·No specific trading figures or price movements were detailed in the title.
VERIFIEDET Stocks·21h★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla's Weekly Trading MetricsAI summary· NEUTRAL
- ·Cipla's share price is currently being updated live.
- ·The company's weekly trading metrics are the focus of these updates.
- ·This information is relevant for Indian stock-market traders.
VERIFIEDET Markets·1d★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla's Market ActivityAI summary· NEUTRAL
- ·Cipla's share price is currently being updated live.
- ·The company's market activity is the subject of the update.
- ·This is a live update on Cipla's stock.
VERIFIEDET Stocks·2d★ ON YOUR LIST
Airtel to Trent: 44 stocks likely to report double-digit profit slump in Q1. Are your stocks on the list?AI summary· NEGATIVE
- ·Motilal Oswal predicts 44 companies, including Bharti Airtel and Trent, may see double-digit profit drops in Q1.
- ·Factors like increased energy costs, reduced demand, and geopolitical issues are anticipated to impact earnings.
- ·Overall corporate profit growth is expected to decelerate during the June quarter.
VERIFIEDET Markets·2d★ ON YOUR LIST
Airtel to Trent: 44 cos likely to report double-digit profit slump in Q1. Are your stocks on the list?AI summary· NEGATIVE
- ·Motilal Oswal predicts 44 companies, including Bharti Airtel and Trent, may see double-digit profit drops in Q1.
- ·Companies like IndiGo, HAL, GAIL, and Cipla are also expected to report profit declines.
- ·Factors such as increased energy costs, reduced demand, and geopolitical issues are anticipated to impact earnings.
VERIFIEDET Stocks·2d★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla's strong 3-month returnAI summary· POSITIVE
- ·Cipla's share price has shown a strong return over the past three months.
- ·The provided text focuses solely on the positive three-month performance of Cipla's stock.
- ·No specific financial figures or market details beyond the three-month return are available in the title.
VERIFIEDET Stocks·3d★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla Achieves 1.25% Return in One WeekAI summary· NEUTRAL
- ·Cipla's share price has achieved a 1.25% return over the past week.
- ·The provided text does not contain further details regarding Cipla's stock performance.
- ·No additional information is available to elaborate on the factors contributing to this return.
VERIFIEDET Markets·3d★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla Achieves 1.25% Return in One WeekAI summary· NEUTRAL
- ·Cipla's share price has achieved a 1.25% return over the past week.
- ·The provided text does not contain further details regarding Cipla's stock performance.
- ·No additional financial information or market analysis is available from the title.
VERIFIEDMint Markets·7d★ ON YOUR LIST
Where will Cipla share price be in the next 3 years?AI summary· NEUTRAL
- ·Pharma stocks are gaining attention due to strong healthcare demand.
- ·There is a rising global need for medicines.
- ·Increasing exports are also contributing to the sector's attention.
VERIFIEDET Markets·7d★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla's strong market performanceAI summary· POSITIVE
- ·Cipla's share price is experiencing strong market performance.
- ·The company's stock is currently trading live.
- ·This indicates a positive trend for Cipla in the stock market.
VERIFIEDET Stocks·7d★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla's strong market performanceAI summary· POSITIVE
- ·Cipla's share price is experiencing strong market performance.
- ·The company's stock is currently trading live.
- ·This indicates a positive trend for Cipla in the stock market.
Google News, NIFTY/SENSEX·11d★ ON YOUR LIST
Nifty Pharma Index Hits Fresh 52-Week High; Dr Reddy’s, Cipla, Ajanta Pharma Lead Rally on GLP-1 Opportunity - India InfolineGoogle News, India stocks·11d★ ON YOUR LIST
Sensex Today | Stock Market Live: Sensex up 130 pts, Nifty at 24,100; Dr Reddy's, Cipla, Max Healthcare top gainers - Moneycontrol.comVERIFIEDET Stocks·11d★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla's Weekly Performance Shows Positive ReturnsAI summary· POSITIVE
- ·Cipla's share price has shown positive returns over the past week.
- ·The company's stock performance is being actively monitored.
- ·Live updates on Cipla's share price are available.
VERIFIEDET Markets·11d★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla's Weekly Performance Shows Positive ReturnsAI summary· POSITIVE
- ·Cipla's share price has shown positive returns over the past week.
- ·The provided text does not contain specific financial figures or detailed performance metrics.
- ·Further details regarding Cipla's weekly performance are not available in the given title.
VERIFIEDET Markets·15d★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla's Performance SnapshotAI summary· NEUTRAL
- ·Cipla's share price is currently being updated live.
- ·The title indicates a performance snapshot of Cipla.
- ·No further details are available from the provided title.
VERIFIEDET Stocks·15d★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla's Performance SnapshotAI summary· NEUTRAL
- ·Cipla's share price is being updated live.
- ·The company's performance is being presented in a snapshot.
- ·This update focuses on Cipla's stock market activity.
VERIFIEDET Markets·16d★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla's strong market returnAI summary· POSITIVE
- ·Cipla's share price is experiencing a strong market return.
- ·The company's stock is showing positive momentum.
- ·Cipla is a significant player in the Indian pharmaceutical market.
VERIFIEDET Finance·17d★ ON YOUR LIST
Indian pharma firms gear up to supply key cancer drug to USAI summary· NEUTRAL
- ·Indian drugmakers are preparing to supply ifosfamide injection to the US.
- ·Zydus, Cipla, Alkem, and Aurobindo Pharma are in discussions to provide the chemotherapy drug.
- ·The US FDA has contacted Indian pharmaceutical bodies to find manufacturers for the drug.
Google News, NIFTY/SENSEX·17d★ ON YOUR LIST
Sensex today | Stock Market Live Updates: Sensex bleeds 350 pts, Nifty below 24,000; Cipla, Sun Pharma lead gainers - BusinessLineGoogle News, NIFTY/SENSEX·17d★ ON YOUR LIST
Nifty Pharma jumps nearly 2%; Dr Reddy's, Sun Pharma and Cipla lead gains, dominate Nifty gainers list - Moneycontrol.comVERIFIEDET Stocks·17d★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla's Price Movement TodayAI summary· NEUTRAL
- ·Cipla's share price is experiencing movement today.
- ·The title indicates live updates on Cipla's stock.
- ·No specific price details or market performance data are available in the provided title.
VERIFIEDET Markets·17d★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla's Stock Price MovementAI summary· NEUTRAL
- ·Cipla's stock price is currently experiencing movement.
- ·The article provides live updates on Cipla's stock price.
- ·The focus is on the stock price movement of Cipla.
VERIFIEDET Stocks·18d★ ON YOUR LIST
Market trading guide: Cipla among 2 stock recommendations for TuesdayGoogle News, NIFTY/SENSEX·18d★ ON YOUR LIST
Nifty 50 June 22, 2026, Gainers: Cipla, Tech Mahindra, Dr Reddy's Lead - HDFC SkyVERIFIEDET Stocks·18d★ ON YOUR LIST
Cipla Share Price Live Updates: Cipla's Stock Price SurgeAI summary· NEUTRAL
- ·Cipla's stock price experienced a surge.
- ·The title of the article is 'Cipla Share Price Live Updates: Cipla's Stock Price Surge'.
- ·No further details are available in the provided text.
Google News, India stocks·18d★ ON YOUR LIST
Sensex today | Stock Market Live Updates: Sensex up 350 pts, Nifty holds above 24,100; Reliance, Cipla lead gains - BusinessLineVERIFIEDET Markets·18d★ ON YOUR LIST
Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?AI summary· POSITIVE
- ·Cipla shares increased by 4% after Citi initiated a 90-day Positive Catalyst Watch.
- ·Citi's optimism is driven by potential US approvals for gFlovent and gVentolin, and a US business rebound.
- ·The company's domestic performance is strong, supported by its respiratory portfolio, with attractive valuations noted.
Google News, NIFTY/SENSEX·18d★ ON YOUR LIST
Sensex Today | Stock Market Live: Sensex up 440 pts, Nifty at 24,150; Cipla, RIL, TMPV top gainers - Moneycontrol.comVERIFIEDET Finance·24d★ ON YOUR LIST
Cipla appoints health chief Shivam Puri to lead One India businessAI summary· NEUTRAL
- ·Shivam Puri has been appointed as the new CEO for Cipla's One India Business.
- ·The leadership change will be effective from July 1.
- ·Puri has been heading Cipla Health since 2019.